These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 28827754)

  • 21. Evaluation of immune responses to combined hepatitis A and B vaccine in HIV-infected children and children on immunosuppressive medication.
    Belderok SM; Sonder GJ; van Rossum M; van Dijk-Hummelman A; Hartwig N; Scherpbier H; Geelen S; Speksnijder AG; Baaten G; van den Hoek A
    Vaccine; 2013 Aug; 31(38):4156-63. PubMed ID: 23845818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B vaccine: a seven-year study of adherence to the immunization guidelines and efficacy in HIV-1-positive adults.
    Bailey CL; Smith V; Sands M
    Int J Infect Dis; 2008 Nov; 12(6):e77-83. PubMed ID: 18723381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occult hepatitis B virus infection and S gene escape mutants in HIV-infected patients after hepatitis B virus vaccination.
    Aghakhani A; Mohraz M; Aghasadeghi MR; Banifazl M; Vahabpour R; Karami A; Foroughi M; Ramezani A
    Int J STD AIDS; 2016 Oct; 27(11):967-72. PubMed ID: 26384943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Seroconversion in response to a reinforced primary hepatitis B vaccination in children with cancer].
    Villena R; Zubieta M; Hurtado C; Salgado C; Silva G; Fernández J; Villarroel M; Fernández M; Brahm J; O'Ryan M; Santolaya ME
    Rev Chil Pediatr; 2015; 86(4):236-43. PubMed ID: 26298296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High rates of serological response to a modified hepatitis B vaccination schedule in HIV-infected adults subjects.
    Potsch DV; Oliveira ML; Ginuíno C; Miguel JC; Oliveira SA; Silva EF; Moreira RB; Cruz GV; Oliveira AL; Camacho LA; Barroso PF
    Vaccine; 2010 Feb; 28(6):1447-50. PubMed ID: 19995540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220.
    Overton ET; Kang M; Peters MG; Umbleja T; Alston-Smith BL; Bastow B; Demarco-Shaw D; Koziel MJ; Mong-Kryspin L; Sprenger HL; Yu JY; Aberg JA
    Vaccine; 2010 Aug; 28(34):5597-604. PubMed ID: 20600512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune response to the hepatitis B vaccine among HIV-infected adults in Uganda.
    Seremba E; Ocama P; Ssekitoleko R; Mayanja-Kizza H; Adams SV; Orem J; Katabira E; Reynolds SJ; Nabatanzi R; Casper C; Phipps W
    Vaccine; 2021 Feb; 39(8):1265-1271. PubMed ID: 33516601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Longitudinal Hepatitis B Vaccine Cohort Demonstrates Long-lasting Hepatitis B Virus (HBV) Cellular Immunity Despite Loss of Antibody Against HBV Surface Antigen.
    Simons BC; Spradling PR; Bruden DJ; Zanis C; Case S; Choromanski TL; Apodaca M; Brogdon HD; Dwyer G; Snowball M; Negus S; Bruce MG; Morishima C; Knall C; McMahon BJ
    J Infect Dis; 2016 Jul; 214(2):273-80. PubMed ID: 27056956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis B vaccination in human immunodeficiency virus-infected adults receiving hemodialysis.
    Ahuja TS; Kumar S; Mansoury H; Rodriguez H; Kuo YF
    Kidney Int; 2005 Mar; 67(3):1136-41. PubMed ID: 15698455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Baseline Circulating Activated TFH and Tissue-Like Exhausted B Cells Negatively Correlate With Meningococcal C Conjugate Vaccine Induced Antibodies in HIV-Infected Individuals.
    Milagres L; Silva G; Pereira-Manfro W; Frota AC; Hofer C; Ferreira B; Barreto D; Figueredo M; Coelho B; Villela L; Petrovas C; Koup R
    Front Immunol; 2018; 9():2500. PubMed ID: 30420858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homing defects of B cells in HIV-1 infected children impair vaccination responses.
    Bekele Y; Lemma M; Bobosha K; Yibeltal D; Nasi A; Gebre M; Nilsson A; Aseffa A; Howe R; Chiodi F
    Vaccine; 2019 Apr; 37(17):2348-2355. PubMed ID: 30914222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of HIV-1 exposure and antiretroviral treatment strategies in HIV-infected children on immunogenicity of vaccines during infancy.
    Simani OE; Izu A; Violari A; Cotton MF; van Niekerk N; Adrian PV; Madhi SA
    AIDS; 2014 Feb; 28(4):531-41. PubMed ID: 24468996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Efficacy of vaccination against hepatitis B in adult with HIV infection].
    Kalinowska-Nowak A; Bociaga-Jasik M; Garlicki A; Mach T
    Przegl Epidemiol; 2007; 61(2):339-47. PubMed ID: 17956052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine.
    Roy MJ; Wu MS; Barr LJ; Fuller JT; Tussey LG; Speller S; Culp J; Burkholder JK; Swain WF; Dixon RM; Widera G; Vessey R; King A; Ogg G; Gallimore A; Haynes JR; Heydenburg Fuller D
    Vaccine; 2000 Nov; 19(7-8):764-78. PubMed ID: 11115698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased regulatory T cell counts in HIV-infected nonresponders to hepatitis B virus vaccine.
    del Pozo Balado Mdel M; Leal M; Méndez Lagares G; Mata RC; López-Cortés LF; Viciana P; Pacheco YM
    J Infect Dis; 2010 Aug; 202(3):362-9. PubMed ID: 20560766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistent and transient hepatitis B virus (HBV) infections in children born to HBV-infected mothers despite active and passive vaccination.
    Boot HJ; Hahné S; Cremer J; Wong A; Boland G; van Loon AM
    J Viral Hepat; 2010 Dec; 17(12):872-8. PubMed ID: 20051008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired Phenotype and Function of T Follicular Helper Cells in HIV-1-Infected Children Receiving ART.
    Bekele Y; Amu S; Bobosha K; Lantto R; Nilsson A; Endale B; Gebre M; Aseffa A; Rethi B; Howe R; Chiodi F
    Medicine (Baltimore); 2015 Jul; 94(27):e1125. PubMed ID: 26166114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis B vaccination and risk of hepatitis B infection in HIV-infected individuals.
    Landrum ML; Hullsiek KH; Ganesan A; Weintrob AC; Crum-Cianflone NF; Barthel RV; O'Connell RJ; Fieberg A; Chun HM; Marconi VC; Dolan MJ; Agan BK;
    AIDS; 2010 Feb; 24(4):545-55. PubMed ID: 19487908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis B virus vaccination in HIV-infected people: A review.
    Catherine FX; Piroth L
    Hum Vaccin Immunother; 2017 Jun; 13(6):1-10. PubMed ID: 28267387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three vs Four Dose Schedule of Double Strength Recombinant Hepatitis-B Vaccine in HIV-infected Children: A Randomized Controlled Trial.
    Jain P; Dewan P; Gomber S; Kashyap B; Raizada A
    Indian Pediatr; 2021 Mar; 58(3):224-228. PubMed ID: 33713056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.